MYCN regulates oncogenic MicroRNAs in neuroblastoma

✍ Scribed by Johannes H. Schulte; Sebastian Horn; Tobias Otto; Birgit Samans; Lukas C. Heukamp; Ursula-Christa Eilers; Michael Krause; Kathy Astrahantseff; Ludger Klein-Hitpass; Reinhard Buettner; Alexander Schramm; Holger Christiansen; Martin Eilers; Angelika Eggert; Bernd Berwanger

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: French
• Weight: 472 KB
• Volume: 122
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.23153

✦ Synopsis

Abstract

MYCN amplification is a common feature of aggressive tumour biology in neuroblastoma. The MYCN transcription factor has been demonstrated to induce or repress expression of numerous genes. MicroRNAs (miRNA) are a recently discovered class of short RNAs that repress translation and promote mRNA degradation by sequence‐specific interaction with mRNA. Here, we sought to analyse the role of MYCN in regulation of miRNA expression. Using a miRNA microarray containing 384 different miRNAs and a set of 160 miRNA real‐time PCR assays to validate the microarray results, 7 miRNAs were identified that are induced by MYCN in vitro and are upregulated in primary neuroblastomas with MYCN amplification. Three of the seven miRNAs belong to the miR‐106a and miR‐17 clusters, which have previously been shown to be regulated by c‐Myc. The miR‐17–92 polycistron also acts as an oncogene in haematopoietic progenitor cells. We show here that miR‐221 is also induced by MYCN in neuroblastoma. Previous studies have reported miR‐221 to be overexpressed in several other cancer entities, but its regulation has never before been associated with Myc. We present evidence of miRNA dysregulation in neuroblastoma. Additionally, we report miRNA induction to be a new mechanism of gene expression downregulation by MYCN. © 2007 Wiley‐Liss, Inc.